Co-localisation of hepatitis C virus drug-resistant mutations and immune-driven adaptations for genotype 1 and 3: relevance to therapy outcome by Gaudieri, S, Rauch, A, Pfafferott, K, Barnes, E, Cheng, W, Mccaughan, G, Shackel, N, Jeffrey, G, Mollison, L, Baker, R, Furrer, H, Guenthard, H, Klenerman, P, Mallal, S, Roberts, S, Nolan, D, Lucas, M